Brief: Alembic Pharmaceuticals Gets Tax Demand Of 228.3 Mln Rupees, Interest Of 103.8 Mln Rupees
03/07/2025 11:39
July 3 (Reuters) - Alembic Pharmaceuticals Ltd ALEM.NS: GETS TAX DEMAND OF 228.3 MILLION RUPEES, INTEREST OF 103.8 MILLION RUPEES Source text: ID:nNSE1bVJ7R Further company coverage: ALEM.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Alembic Pharmaceuticals
See all newsIndia's Alembic Pharma rises after US FDA approves herpesvirus drug
Brief: Alembic Pharmaceuticals Receives USFDA Final Approval For Valganciclovir Oral Solution 50 Mg/Ml
Brief: Alembic Pharmaceuticals Completes USFDA Bioequivalence Inspection At Vadodara With No Observations
India's Alembic Pharma gains as brokerages optimistic after quarterly profit rise
India's Alembic Pharma posts quarterly profit rise on strong generics demand